Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

Here, we describe the use of spectral-domain optical coherence tomography (SD-OCT) to visualize retinal and ocular structures in vivo in models of retinal degeneration, glaucoma, diabetic retinopathy, and myopia.

Abstract

Spectral-domain optical coherence tomography (SD-OCT) is useful for visualizing retinal and ocular structures in vivo. In research, SD-OCT is a valuable tool to evaluate and characterize changes in a variety of retinal and ocular disease and injury models. In light induced retinal degeneration models, SD-OCT can be used to track thinning of the photoreceptor layer over time. In glaucoma models, SD-OCT can be used to monitor decreased retinal nerve fiber layer and total retinal thickness and to observe optic nerve cupping after inducing ocular hypertension. In diabetic rodents, SD-OCT has helped researchers observe decreased total retinal thickness as well as decreased thickness of specific retinal layers, particularly the retinal nerve fiber layer with disease progression. In mouse models of myopia, SD-OCT can be used to evaluate axial parameters, such as axial length changes. Advantages of SD-OCT include in vivo imaging of ocular structures, the ability to quantitatively track changes in ocular dimensions over time, and its rapid scanning speed and high resolution. Here, we detail the methods of SD-OCT and show examples of its use in our laboratory in models of retinal degeneration, glaucoma, diabetic retinopathy, and myopia. Methods include anesthesia, SD-OCT imaging, and processing of the images for thickness measurements.

Introduction

Spectral-domain optical coherence tomography (SD-OCT) is a precise, high-resolution imaging modality that allows clinicians and researchers to examine ocular structures noninvasively. This imaging technique is based on interferometry to capture three-dimensional retinal images in vivo on a micrometer scale1,2. It has become one of the most frequently used imaging modalities in vision research and in the clinic due to the easy detection and accuracy of pathological features such as structural defects and/or thinning of retinal layers and subretinal fluid3. In research using animal models....

Protocol

All procedures described were approved by the Atlanta Veterans Affairs Institutional Animal Care and Use Committee and conformed to the National Institutes of Health guide for the care and use of laboratory animals (NIH Publications, 8th edition, updated 2011).

NOTE: The SD-OCT system used to develop the protocol below is described in the Table of Materials. While some of the procedures are specific to this particular system, the overall approach can be adapted for .......

Representative Results

SD-OCT is considered successful if high quality images are obtained such that ocular dimensions can be reliably measured. Here, a variety of uses of SD-OCT are illustrated using models of retinal degeneration, glaucoma, diabetic retinopathy, and myopia.

In a light-induced retinal degeneration (LIRD) model, exposure to bright light (10,000 lux) induces degeneration of photoreceptor cells in the retina9. Representative SD-OCT images reveal a thinner outer nuclear layer, w.......

Discussion

High resolution imaging of ocular structures in vivo allows for the assessment of retinal and ocular changes over time. In this protocol, SD-OCT was demonstrated to capture differences in ocular structures in vivo in models of retinal degeneration, glaucoma, diabetic retinopathy, and myopia.

The most critical aspect when performing SD-OCT is obtaining a clear image of the retina or other ocular structure of interest. It is important to take time to make sure the retina is perfectly centered an.......

Acknowledgements

This work was supported by the Department of Veterans Affairs Rehab R&D Service Career Development Awards (CDA-1, RX002111; CDA-2; RX002928) to RSA, Merit Award (RX002615) and Research Career Scientist Award (RX003134) to MTP, Career Development Award (CDA-2, RX002342) to AJF, EY028859 to MTP, NEI Core Grant P30EY006360, Research to Prevent Blindness, and Foundation Fighting Blindness.

....

Materials

NameCompanyCatalog NumberComments
1% tropicamideSandozSandoz #6131403550; NDC- 24208-585-59
0.5% tetracaineAlconNDC 0065-0741-12
AIM-RAS G3 120 VLeica Bioptigen90-AIMRAS-G3-120Specialized platform to hold the OCT Scanner Head for mice
Celluvisc gelREFRESH CELLUVISC#4554; NDC-0023-4554-30
G3 18 mm Telecentric LensLeica Bioptigen90-BORE-G3-18
G3 Mouse LensLeica Bioptigen90-BORE-G3-M
G3 Rat LensLeica Bioptigen90-BORE-G3-R
heating padFabrication11-1130
InVivoVue softwareLeica BioptigenSpecialized software that pairs with the Leica Bioptigen SD-OCT system
MATLABMathworksmathematical modeling program
Mouse/Rat KitLeica Bioptigen90-KIT-M/RMouse/rat rodent alignment system
salineADDIPAK200-39
System Envisu R4300 VHR 120 VLeica Bioptigen90-R4300-V1-120SD-OCT system

References

  1. Wojtkowski, M., et al. Ultrahigh-resolution, high-speed, Fourier domain optical coherence tomography and methods for dispersion compensation. Optics Express. 12 (11), 2404-2422 (2004).
  2. Nassif, N., et al.

Explore More Articles

Optical Coherence TomographySDOCTRetinal DegenerationDiabetic RetinopathyGlaucomaMyopiaRetinal ThicknessAxial LengthRodent ModelsIn VivoRetinal ImagingEye Disease

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved